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ABSTRACT 
Mutations in the RNA-binding protein, RBM10, result in a human syndromic form of 
cleft palate, termed TARP syndrome. A role for RBM10 in alternative splicing 
regulation has been previously demonstrated in human cell lines. To uncover the 
cellular functions of RBM10 in a cell line that is relevant to the phenotype observed 
in TARP syndrome, we used iCLIP to identify its endogenous RNA targets in a 
mouse embryonic mandibular cell line. We observed that RBM10 binds to pre-
mRNAs with significant enrichment in intronic regions, in agreement with a role for 
this protein in pre-mRNA splicing. In addition to protein-coding transcripts, RBM10 
also binds to a variety of cellular RNAs, including non-coding RNAs, such as 
spliceosomal small nuclear RNAs, U2 and U12. RNA-seq was used to investigate 
changes in gene expression and alternative splicing in RBM10 KO mouse mandibular 
cells and also in mouse ES cells. We uncovered a role for RBM10 in the regulation of 
alternative splicing of common transcripts in both cell lines but also identified cell-
type specific events. Importantly, those pre-mRNAs that display changes in 
alternative splicing also contain RBM10 iCLIP tags, suggesting a direct role of 
RBM10 in these events. Finally, we show that depletion of RBM10 in mouse ES cells 
leads to proliferation defects and to gross alterations in their differentiation potential. 
These results demonstrate a role for RBM10 in the regulation of alternative splicing in 
two cell models of mouse early development and suggests that mutations in RBM10 
could lead to splicing changes that affect normal palate development and cause human 
disease. 
 
Keywords: RNA-binding proteins; Alternative splicing; RBM10; iCLIP; mandibular 
cell line; stem cells; TARP syndrome 
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Introduction 
RNA-binding proteins (RBPs) bind cellular RNAs to form ribonucleoprotein (RNP) 
particles with unique specificity that profoundly influence RNA biogenesis and 
function1–3, affecting multiple steps in gene expression. The RBM10 (RNA binding 
motif 10) protein is a member of the RNA-binding motif (RBM) gene family, which 
includes the highly homologous RBM5 and RBM6 proteins. RBM10 (originally 
called S1-1), is alternatively spliced to produce two mRNA variants (v1 and v2), 
which differ in the inclusion/exclusion of exon 4, giving rise to two protein isoforms 
of 930 and 853 amino acids, respectively4,5. Both protein variants comprise several 
functional domains that bind to RNA, such as two RNA recognition motifs (RRM), a 
RanBP2-type zinc finger motif, a C2H2 Zn finger domain and a C-terminal G patch 
domain5. RBM5, also known as Luca-15/H37, is a gene frequently inactivated in lung 
cancers and overexpressed in breast tumors and regulates alternative splicing of 
apoptosis-related genes6,7. 
 Mutations in RMB10 were originally found in two families manifesting an X-
linked syndromic form of cleft palate, termed TARP (for talipes equinovarus, atrial 
septal defect, Robin sequence, and persistent left superior vena cava). This syndrome 
comprises Pierre–Robin sequence (micrognathia, glossoptosis, and cleft palate), 
talipes equinovarus, atrial septal defect (ASD), and persistence of the left superior 
vena cava and results in pre- or postnatal lethality in affected males8,9. The first two 
families were quite similar in phenotype, with uniform early lethality although a 
confirmatory case report showed survival into childhood. More recently, three 
families with mutations in RBM10, in which the affected males were more 
phenotypically diverse, were identified10. All six reported causative mutations in 
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TARP syndrome are predicted to result in loss of function of RBM10 illustrating that 
this gene is critical for normal mammalian development.  The orthologous murine 
Rbm10 isoform 1 gene product is 96% identical to the human protein. It is expressed 
in midgestation mouse embryos in the branchial arches and limbs, consistent with the 
human malformations observed in patients with TARP syndrome8. 
 Identification of endogenous RNA targets for individual RBPs is crucial to 
understand their role in RNA biogenesis. A role for RBM10 in pre-mRNA splicing 
was initially suggested by the identification of RBM10 as a component of pre-
spliceosomal A and B complexes11–13, and for its interaction with the alternative 
splicing regulator SRrp8614.  Moreover, RBM10 was found to modulate alternative 
splicing (AS) of Fas and Bcl-x genes15. A variant of the CLIP (crosslinking and 
immunoprecipitation) protocol, termed PAR-CLIP was used to identify binding sites 
of RBM10 in HEK 293 cells. This led to the identification of thousands of binding 
sites of RBM10, many occurring in the vicinity of splice sites. This study also 
revealed an extensive role for RBM10 in splicing regulation, in particular in the 
regulation of the exon skipping-type of AS regulation16. A second study using other 
variant of CLIP (CLIP-Seq) and splicing-sensitive microarrays identified RBM10 
targets in HeLa cells. As was the case in HEK 293 cells, RBM10 was also found to 
have a role in splicing regulation, in particular functioning in antagonistic manner to 
the related proteins, RBM5 and RBM6 in the regulation of alternative splicing of 
NUMB, a regulator of the Notch signaling pathway17. 
 To understand how RBM10 loss of function leads to human disease, we aimed to 
identify endogenous RNA targets of RBM10 in a mouse mandibular embryonic cell 
line, which is relevant to the phenotype observed in TARP syndrome. For this, we 
used the iCLIP variant protocol that allows the mapping of protein-RNA interactions 
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at an individual nucleotide resolution18,19. We observed that RBM10 binds 
preferentially to intronic regions of protein-coding genes. This was complemented by 
RNA-seq profiling of RBM10 knock-out mouse mandibular cells as well as mouse 
embryonic (ES) stem cells with disrupted RBM10 expression. This analysis revealed 
an extensive role for RBM10 in the regulation of alternative splicing, affecting the 
regulation of several alternative cassette exons in both cell types (mandibular and ES 
cells), but also displaying cell-type specific regulation of AS. In mandibular cells, the 
overlap of the iCLIP and the RNA-seq data revealed a direct role of RBM10 in the 
silencing of alternative cassette exons. Taken together, our analyses provide evidence 
for a widespread role for RBM10 in the regulation of alternative splicing in a mouse 
cell line, with relevance to the human disease. This strongly suggest that 
misregulation of alternative splicing upon loss of function of RBM10 could lead to 
the TARP syndrome. 
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RESULTS 
Genome-wide mapping of RBM10 binding sites using iCLIP 
We used iCLIP (individual-nucleotide resolution UV crosslinking and 
immunoprecipitation) to determine the RNA-binding landscape of RBM10 in a mouse 
mandibular MEPA (Mouse Embryonic Pharyngeal Arch) cell line, since this is more 
relevant to the phenotype observed in TARP syndrome20. The RBM10 protein is 
highly conserved between man and mouse, and the spatiotemporal pattern of 
expression of the mouse gene during embryogenesis is very consistent with the 
phenotypes observed in TARP patients, which harbor loss of function mutations in 
RBM108–10. We carried out four independent iCLIP experiments using an antibody 
that recognizes the two major isoforms of the mouse RBM10 protein (variants 1 and 
2) in mouse mandibular MEPA cells. As a control, we performed an 
immunoprecipitation using rabbit IgG. The RNA-RBM10 protein complexes were 
extracted from the membrane (Fig. 1A). Considering the small difference of size 
between the two RBM10 isoforms, the two different complexes cannot be analyzed 
separately. For each experiment, an extraction was also performed for the control lane 
(immunoprecipitation using IgG) at the same level in the membrane.  
 Libraries were prepared for each RBM10 iCLIP and its equivalent control and 
sequenced on an Illumina platform. Identical reads coming from the PCR 
amplification were removed and following removal of the adapter sequence, short 
reads were discarded (Fig. 1B). 11.9M reads were obtained for the four RBM10 
iCLIP and 6.6M for the control (Fig. 1B). After attribution of the reads to each 
individual experiment using the barcode, reads were mapped to the mouse genome 
using Bowtie. Around 75% of the reads of the different experiments were mapped to 
the genome (Fig.1B). For the subsequent analysis, we decided to keep the reads that 
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can be uniquely mapped to the genome. For each iCLIP replica experiment (RBM10 
and control), the distinct cross-linked nucleotides were determined and associated to a 
number of reads (Fig. S1A). This analysis gave us a total of 6.8M cross-linked 
nucleotides present in all four iCLIP experiments (Fig. 1C). However, these positions 
can also be present in the equivalent control or be only supported by a small number 
of reads. Thus, these positions were filtered using different criteria. For each 
independent iCLIP experiment, we only use those cross-linked positions that had at 
least two-fold more reads in the RBM10 iCLIP, as compared to the matching IgG 
iCLIP. The correlation between the four iCLIP experiments for these 4.9M cross-
linked positions was analyzed and confirmed a good reproducibility for all RBM10 
iCLIP experiments (Fig. S1B). In comparison, we observed a strong reduction of the 
correlation coefficient when we compared each RBM10 iCLIP with its equivalent 
control (Fig. S1B).  
 Binding sites of RBM10 protein correspond to cross-linked nucleotides supported 
by a large number of reads that are enriched as compared to the control iCLIP. First, 
we decided, to obtain a list of ‘strong’ binding sites of RBM10 by keeping the cross-
linked positions containing at least 1 read in each RBM10 iCLIP (if the control does 
not have any reads) or a two-fold difference compared to the control. This stringent 
analysis gave us a total of 20,866 cross-linked nucleotides (‘strong’ list) that are 
common to the four RBM10 iCLIP experiments (Fig. 1C, Table S1). We sometimes 
found adjacent cross-linked nucleotides and this observation probably reflects the fact 
that the binding of RBM10 is not limited to one individual nucleotide but probably 
spans several nucleotides. Taking this into account, we joined together the adjacent 
cross-linked nucleotides and estimated the number of ‘strong’ binding sites of 
RBM10 protein at 15,627 (Fig.1C). Then, in order to have a more complete list of 
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RBM10 binding sites (‘full’ list), we focused our analysis to cross-linked nucleotides 
present in at least three out of four RBM10 iCLIP experiments. In this case, the 
number of cross-linked nucleotides was 81,562 and the number of RBM10 binding 
sites was estimated at 60,346 (Fig. 1C, Table S1). To validate this analysis, we looked 
at the number of reads associated to each cross-linked nucleotide for the list of 
‘strong’ and ‘full’ RBM10 binding sites. In comparison to the list of total cross-linked 
positions defined by all the iCLIP experiments, the proportion of cross-linked 
nucleotides supported by at least 10 reads increases drastically for the list of ‘full’ 
RBM10 binding sites and even more for the list of ‘strong’ RBM10 binding sites (Fig. 
1D). The number of RBM10 binding sites in mouse mandibular cells is in the same 
range as the one obtained using the PAR-CLIP method in human HEK 293 cells16, 
suggesting similar binding properties between mouse and human RBM10 protein and 
within different cell types.  
  
iCLIP annotation and binding motifs 
The annotation of the full list of RBM10 binding sites was performed using the cross-
linked nucleotide positions (Fig.  2) or the number of reads (Fig. S2). In both cases, 
this analysis showed a clear enrichment of RBM10 binding sites towards protein-
coding transcripts (Fig. 2A and S2A) and more specifically towards introns of these 
protein coding genes (Fig. 2B and S2B). We also observed binding of RBM10 to non-
coding (ncRNAs) RNAs (Fig. 2A and S2A), which are probably under evaluated as 
only uniquely mapped reads were kept. This analysis revealed that RBM10 binds 
transcripts of around 6,000 mouse protein coding genes (with a strong binding site for 
3,000 genes), thus, associating with transcripts of around 30% of all annotated mouse 
protein coding genes.  
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 We observed that the distribution of RBM10 cross-linked nucleotides within the 
intron shows a clear enrichment on the 3’side of the intron, with a small peak of 
RBM10 binding close to the 5’ splice site (Fig. 2C). RBM10 preferentially binds to 
the 3’side of the intron, from – 150 to – 50 nucleotides upstream of the 3’ splice site. 
In humans, the branch point (BP) position has been well defined and is in average 
located between 18 and 35nt upstream of the 3’ splice site21. However, BP recognition 
seems to be more relaxed than previously assumed and is highly dependent on the 
presence of downstream polypyrimidine tracts22. Mouse branch point positions 
display a similar pattern confirming that RBM10 binds preferentially upstream of the 
branch point23.  
 A large number of RBPs recognize their RNA targets in a sequence-specific 
manner24,25. It has been shown that rat RBM10 protein binds in vitro to RNA 
homopolymers, with a preference for G and U polyribonucleotides4. The iCLIP data 
allowed us to search for RBM10 binding sites within the list of ‘strong’ RBM10 
cross-linked nucleotides. Taking the top 1,000 cross-linked nucleotides in introns 
(ranked by the sum of reads in all 4 iCLIP experiments), we observed that cytosine 
represented more than 80% of the cross-linked nucleotides (Fig. 2D). This C 
nucleotide bias could be directly related to RBM10 specificity as CLIP techniques are 
only subject to a modest uridine preference caused by UV-C cross-linking26. We then 
used the sequences surrounding the cross-linked nucleotides to obtain a consensus-
binding motif, using the MEME software27. We obtained one significant motif 
enriched in C nucleotides (Fig. 2E). We also look for enriched pentamers in the 20nt 
sequences that surround the top 1,000 RBM10 cross-linked nucleotides. As control, 
we used 20 nt sequence chosen randomly within the same introns bound by RBM10, 
and we calculated a Z-score for each pentamer. The top three enriched pentamers are 
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TCCAA, CCAAA and CCCCA.  In fact, all top 15 enriched pentamers contains at 
least two consecutive C nucleotides (Fig. S3). These data show a strong binding 
preference for RBM10 for motifs containing at least two consecutive C nucleotides 
followed by a T or an A. This is consistent with one of the motifs identified by CLIP-
seq for the human RBM10 protein in HeLa cells17. 
 
RBM10 binds to spliceosomal small nuclear RNAs   
As described above, RBM10 also binds to non-coding RNAs (Fig. 2A and S2A) and 
we noticed a large number of reads corresponding to snRNAs. We decided to map 
reads directly to snRNA sequences to better characterize this binding (see details in 
methods).  RBM10 preferentially binds to specific snRNAs, with a high enrichment of 
reads observed for the U12 minor spliceosomal snRNA, but we also observed 
significant binding to spliceosomal U2 snRNAs (Fig. 3A), as was also described in 
human cells16. This data could suggest a role of RBM10 in the processing of snRNAs. 
Alternatively, and perhaps more likely taking into account the binding of RBM10 to 
introns in the vicinity of the branch point, we speculate that RBM10 interacts with the 
U2/U12 snRNP complex, as well as with the mRNA, during splicing and potentially 
regulates their association. In agreement with an enrichment of RBM10 binding to 
U12 snRNA, we observed that the proportion of U12 introns bound by RBM10 is 
higher compared to that of U2 introns (Fig. 3B). RBM10 binding in U12 introns is 
closer to the 3’ splice site, as compared to U2 snRNAs (Fig. 3C). This probably 
reflects the fact that most U12 introns do not contain a polypyrimidine tract and that 
RBM10 binding is relative to the branch point (BP), which is closer to the 3’ splice 
site for U12 introns28. To validate this hypothesis, we predicted the branch point 
location on U2 and U12 introns bound by RBM10 and analyzed the distance between 
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RBM10 cross-linked nucleotides and the BP adenosine. We observed a strong 
enrichment of RBM10 binding upstream of the branch point (around -35nt) (Fig. 3D). 
The profile is similar for U2 and U12-dependent introns suggesting that the distance 
between RBM10 binding and the branch point is important for splicing.  In order to 
better characterize RBM10 binding to U2 and U12 snRNAs, we mapped the iCLIP 
reads to the consensus sequences of U2 and U12 and defined the cross-linked 
nucleotides.  RBM10 binding was observed in different region of U12 snRNA (Fig. 
S4A and C) while RBM10 binding to U2 snRNA is preferentially localized to the first 
stem loop (Fig. S4B and D). RBM10 binds close to the branch point recognition 
region and this is probably important to regulate the interaction between U2/U12 and 
the pre-mRNA. 
 
A role for RBM10 in alternative splicing in mandibular cells 
In order to globally analyze the effects of RBM10 in alternative splicing, we 
performed RNA-Seq on polyA+ RNA isolated from cells in which RBM10 
expression was disrupted. For this, we used the CRISPR/Cas9n system to generate a 
knock-out of RBM10 in mouse mandibular cells. To avoid off-target effects, we used 
the double-nicking strategy using a Cas9 nickase mutant and we obtained two KO cell 
lines (KO1, KO2) containing a deletion in exon 3 and two additional KO cell lines 
(KO3 and KO4) harboring deletions in exon 9 (Fig. 4A). The screening of RBM10 
KO cells was carried out by Western blot analysis and showed the absence of both 
isoforms of RBM10 protein in the four selected RBM10 KO cells (Fig. 4B). The 
RBM10 KO clones can contain one or two mutated copies of the RBM10 gene, which 
maps to the X chromosome, depending whether the clone is male or female. Mouse 
mandibular cell lines were obtained from dissection of a whole litter of embryos 
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without sex assignment20, so we decided to genotype the WT population as well as 
some positive clones. While the WT population of mandibular (md) cells showed a 
mixed population of female and male cells, all the studied KO clones were female 
(Fig. S5A) and thus contained two copies of RBM10 genes. We sequenced RBM10 
exon 3 and exon 9 from RBM10 KO cells to identify the specific deletions causing 
RBM10 KO (Fig. S5B). We identified two different alleles of KO3 containing two 
different deletions in exon 9. However, the sequencing of clones KO1, KO2 and KO4 
showed only one version of the mutated exon suggesting that both copies of RBM10 
gene are similar in each clone. The presence of identical deletion in both alleles of the 
targeted gene has been observed in other studies using CRISPR technology and is 
likely explained by an inter-allelic gene conversion event29. 
 RNA-seq analysis was performed for each RBM10 KO cell line and compared to 
the WT mandibular MEPA cells that were analyzed in triplicate. Gene expression 
analysis was performed using Sailfish for mapping and transcript quantification30, 
followed by DESeq to assess  differential expression31. As expected, the data obtained 
for the three WT md cells clustered strongly together while the four RBM10 KO 
samples formed a separate group with bigger distance between each other, as 
expected for four independent biological replicate KO cell lines (Fig. 4C). 
Considering a 1.5-fold change and a <0.05 P-value, 288 genes displayed differential 
expression between WT and KO md cell lines, with 146 genes up-regulated, and 142 
genes down-regulated (Table S2). We then assessed splicing changes in the RBM10 
KO cell lines using the SUPPA tool32, which calculates the PSI ("Percentage Spliced 
In") value for each splicing event extracted from the annotation of the mm10 mouse 
genome. We defined a list of differential splicing events based on the changes of PSI 
but also taking into consideration the standard deviation between replicates and the 
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overlap between the two set of data (WT vs KO) (see details in Methods). As a result, 
we obtained a list of 786 splicing events that changed in the knockout cell lines (Table 
S3). These events fall into several categories but we identified a large number of 
alternative cassette exons, in particular inclusion of cassette exons upon abrogation of 
RBM10 expression (Fig. 4D). 
 
A role for RBM10 in alternative splicing in embryonic (ES) stem cells 
Since RBM10 is ubiquitously expressed, its role in the regulation of housekeeping or 
ubiquitously expressed transcripts is probably conserved in different cell types or 
during development33. However, RBM10 might also play a role in the regulation of 
transcripts with specific expression profile. To assess how RBM10 affects splicing in 
a different mouse cell line, we took advantage of the availability of an RBM10 KO ES 
cell line. We chose the male gene trap cell line Rbm10Gt(CSI176)Byg . This cell line is 
hemizygous for the RBM10 mutated allele present in the single X chromosome, with 
an insertion on the fifth intron of this gene (Fig. S6A). We confirmed the presence of 
the insert at the genomic level (Fig. S6B). We could also detect a fusion transcript 
between the upstream part of RBM10 gene and the insertion by RT-PCR analysis. 
Furthermore, we could not detect any full-length RBM10 transcript (Fig. S6C) and we 
confirmed the absence of RBM10 protein by Western blot analysis (Fig. S6D).  
 RNA-seq analysis was performed for the RBM10 KO ES cell and compared to 
control cells (parental E14 cell line) that were analyzed in triplicate. The heatmap 
shows that the samples are strongly clustered, as expected for replicates of the same 
cell line (Fig. S7A). We also detected more significant changes in terms of gene 
expression and splicing in ES cells in comparison to mandibular cells probably 
because of the lower variability between replicates. Considering a two-fold change 
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and a P-value below 0.01, we found 653 genes upregulated and 772 genes down-
regulated in RBM10 KO ES cells (Table S2). The splicing analysis revealed a change 
in 2,967 splicing events (Table S3). Again, changes for all categories of events were 
reported but we observed a higher number of inclusion of alternative cassette exons 
upon RBM10 depletion (Fig. S7B). 
 
Comparison between mandibular and ES RNA-seq 
We compared the effect of abrogating RBM10 expression in md MEPA cells 
(CRISPR-mediated KOs) and ES cells (gene-trap) to assess a putative cell-type 
specific role for RBM10 in splicing regulation. In terms of gene expression, only 12 
genes were shown to be up-regulated in both cell lines, with 10 genes down-regulated 
in both cell types. In contrast, in terms of splicing, we found 111 event changes 
identified in both mandibular and ES cells (Fig S8A). The overlap between splicing 
events in both cell lines is significant for alternative cassette exons and also for intron 
retention events (Fig. S8A). Among the 60 shared alternative cassette exons, 44 
correspond to included cassette exon and 16 are skipped cassette exons (Fig. 5A). For 
validation, we selected a small subset of genes that showed large splicing changes in 
both mandibular and ES cells, as revealed by RNA-seq analysis, but also display a 
similar expression level in both cell lines. We confirmed by RT-PCR the cassette 
exon inclusion of two ubiquitously expressed genes, the protein kinase WNK1, a 
member of the WNK subfamily of serine/threonine protein kinases34 and also of the 
CDKN1A Interacting Zinc Finger Protein 1, CIZ135 (Fig. 5B). We also validated 
splicing changes for AGFG236, a co-factor of the Rev protein, and also for the 
oxidation resistance gene OXR137 (Fig. 5B). We also identified cell line-enriched 
alternative splicing events. The inclusion of a cassette exon in the ST7 pre-mRNA 
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was detected in both mandibular and ES cells; however, the effect is stronger in 
mandibular cells where ST7 expression is higher (Fig. 5B). Its cellular function has 
not been precisely determined but ST7 has been linked with cancer, including 
mandibular and jaw cancer (Malacard Human Disease database). By contrast, splicing 
changes of NDRG2, a N-Myc downstream-regulated gene, were only observed in ES 
cells where the gene is expressed (Fig. 5B). To understand if the splicing differences 
observed between cell lines is linked to the expression level of the gene, we looked at 
the difference of expression between mandibular MEPA and ES cells for genes with 
mandibular-specific splicing changes, ES-specific splicing changes, or common 
events. Globally, genes with mandibular-specific splicing changes have a higher 
expression in mandibular cells (Fig S8B). Similarly, genes with ES-specific splicing 
changes have a higher expression in ES cells. Most of the genes that are spliced-
regulated in both cell lines show similar level of expression. This data indicates that 
RBM10 regulates the splicing of ‘housekeeping’ genes but also of cell-specific 
expressed genes (Fig. S8B).  
 Next, we attempted to uncover whether the effect of RBM10 on the expression 
and/or splicing of target genes was direct. For this, we analyzed the overlap of bound 
and regulated RNA targets by comparing RMB10 binding as determined by iCLIP 
with RNA-seq data in mandibular mouse cells that were depleted of RBM10. While 
only 20% of the up- and down-regulated genes in RBM10 KO md cells are bound by 
RBM10 (CLIP+), 60% of the spliced-regulated genes are CLIP+ (Fig. S9). To 
understand how RBM10 directly regulates splicing, and in particular alternative 
cassette exons, we used the iCLIP data to draw an RNA map in mouse mandibular 
cells (Fig. 5C)38. We observed binding of RBM10 to downstream introns for both 
enhanced and silenced alternative exons; however specific RBM10 binding to 
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upstream introns was noticed only in the case of silenced alternative exons. This 
suggests, that RBM10 binding close to the 3’ splice site promotes the skipping of the 
downstream exon. We attempted to assess whether those changes in AS elicited by 
RBM10 were intrinsic to a particular exon-intron architecture. We only observed 
significant differences for exon length, as shown by included exons in RBM10 KO 
cells, which are shorter, whereas skipped exons are longer, as compared to cassette 
exons not affected by RBM10 in these cells. (Fig. S10).  
 
RBM10 KO phenotype 
Next, we characterized the phenotypes of RBM10 KO cell lines. We observed a 
strong effect of abrogating RBM10 expression in ES cells that displayed a marked 
decrease in growth (Fig. 6A). As the TARP syndrome affects early development, we 
tested whether RBM10 KO ES cells have conserved their differentiation potential. We 
induced embryonic body formation by culturing the cells in suspension without 
leukemia inhibitory factor (LIF). As expected, wild-type cells formed the 
characteristic three-dimensional multicellular aggregates called embryoid bodies 
(EBs) (Fig. 6B). By contrast, there was drastic decrease in the size of the embryoid 
bodies in RBM10 KO cells (Fig. 6B). The growth defect observed prior to 
differentiation probably contributes to this effect. It has been observed previously that 
lineage-specific differentiation could be affected by the size of the EBs during the 
differentiation process in vitro39. For this reason, we decided not to assess the 
expression of differentiation markers, as it would not be indicative of a biological 
effect of RBM10 knockout in vivo. In the case of mandibular cells, depletion of 
RBM10 seems to affect slightly their growth rate. It should be noted that mouse md 
(MEPA) cells were obtained from early embryos from CD1 females crossed with a 
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male “Immortomouse’, which carries a constitutively expressed SV40 T (tumor) 
antigen (Tag) transgene, which could potentially affect its transformation potential20. 
Nonetheless, when comparing WT MEPA md cells with the RBM10 KO clones, three 
of the KO cell lines (KO 2, 3 and 4 lines) displayed a decrease of growth, as 
compared to the WT cells (Fig. 6C). This effect in cell growth is different from the 
increase in proliferation observed following RBM10 knockdown in HeLa cells17, 
which was mainly attributed to the role of RBM10 in controlling the alternative 
splicing of the NUMB gene, an event that acts to regulate the proliferative capacity of 
cancer cells17. In these cells, direct binding of RBM10 upstream of the alternative 
exon 9 of NUMB gene leads to skipping of this exon and produces a NUMB isoform 
that acts as a negative regulator of the Notch signaling pathway. RBM10 was shown 
to antagonize the function of two other protein family members, RBM5 and RBM6 in 
the control of NUMB AS. By contrast, in mouse mandibular cells, we did not observe 
any binding of RBM10 upstream of the mouse alternative exon 9 of NUMB gene. 
Nonetheless, we analyzed NUMB splicing profile for WT and RBM10 KO in both ES 
cells and mandibular cells. In agreement with the observed lack of binding, there 
seems to be no effect of RBM10 in the splicing regulation of NUMB exon 9 (Fig. 
S11). This most likely reflects both differential roles for RBM10 in splicing 
regulation in cells derived from different origin and/or species-specific differences. 
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Discussion 
Mutations in RBM10 have been found to cause an X-linked human disorder, termed 
TARP syndrome. Here, we used the iCLIP protocol to identify endogenous RNA 
targets for RBM10 in a mouse mandibular cell line. Due to the very high conservation 
of the mouse and human RBM10 proteins and the study of a cell line model of early 
palate development, our analysis is relevant to the phenotypes observed in patients 
with loss-of-function RBM10 mutations. We observed a clear enrichment of RBM10 
binding to introns of protein-coding genes and also to spliceosomal small nuclear 
RNAs of both canonical as well as minor spliceosomes. RBM10 preferentially binds 
in the proximity of the branch point (BP) and the 3’ splice site, which is in agreement 
with its specific association with the U2 and U12 snRNP complex. RBM10 iCLIP 
data revealed a strong enrichment for a cross-link C nucleotide and subsequently the 
identified enriched motifs contained at least two consecutive Cs, and resembled 
binding motifs identified in human cells17. 
 We combined the iCLIP analysis with full transcriptome analysis of gene 
expression and splicing changes upon RBM10 inactivation in both mouse mandibular 
cells and also in ES cells. We could define a clear role for RBM10 in alternative 
splicing regulation. Thus, RBM10 has a role in cell house-keeping function by 
controlling the splicing of a set of genes expressed in early development, in stem cells 
as well as in embryonic differentiated mandibular cells. Combining iCLIP and RNA-
seq data allowed us to draw an RBM10 RNA map, which suggested that the binding 
of RBM10 in the vicinity of 3’splice sites leads to the silencing of the downstream 
exon. This is in agreement with the studies carried out in human cell lines16,17. The 
iCLIP data also shows that RBM10 binds U12 snRNA as well as U12 splicing-
dependent introns. This suggests a role for RBM10 in splicing regulated by the minor 
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spliceosome. However, we did not notice any defect in the splicing of U12 introns in 
the RNA-seq data of RBM10 KO cells. We do not know if RBM5 and RBM6 bind 
also to U12 introns but the absence of a defect in RBM10 KO cells could be explained 
by the redundant function of RBM5 and RBM6 proteins.  
 RBM10 was also found to be mutated in lung adenocarcinomas40 and there is 
growing evidence for a role of RBM10 as a tumor suppressor that acts to repress the 
Notch signaling pathway and cell proliferation, by affecting the regulation of NUMB 
alternative splicing41. By contrast, we did not observe a role for RBM10 in the 
regulation of NUMB AS neither in mouse ES cells nor in embryonic mandibular cells. 
Moreover, RBM10 knockdown leads to slower growth rather than to proliferation, 
perhaps suggesting that a major role for RBM10 in cell growth is exerted earlier in 
development. Abrogating RBM10 expression in mouse ES cells led to a drastic 
decrease in cell growth and also dramatically affected the formation of embryoid 
bodies (Fig. 6). Among the list of splicing changes detected in RBM10 KO ES cells 
(Table S3), several genes could contribute to a proliferation phenotype, such as the 
pro-apoptotic Bcl-2 family member Bim (also known as Bcl2l11)42 or the T-box 
transcription factor, TBX3, that promotes cell proliferation43.  
 The TARP syndrome is a pleiotropic syndrome, affecting different aspects of 
development. Thus, it could be caused by many different alterations in gene 
expression and/or alternative splicing induced by RBM10 loss-of-function. As an 
example, depletion of RBM10  led to splicing changes in the EPN1 pre-mRNA, 
which is involved in the Notch signaling pathway44. Splicing changes were also 
observed in ES cells for the LEF1 gene that is required for the Wnt signaling 
pathway45, which is crucial for several steps of embryo development including palate 
morphogenesis46. Interestingly, we also detected splicing changes in the C2CD3 pre-
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mRNA, which is mutated in the oral facial digital syndrome47 and in  OPA1, whose 
mutations provoke an optic atrophy, a phenotype observed in TARP syndrome9. As 
was previously observed in human cells, RBM10 is also required for the splicing of 
CASK gene16. 
 In summary, we have described the RNA-binding landscape of RBM10 in a mouse 
mandibular cell line and have clearly established a role for this RBP in alternative 
splicing regulation. The fact that RBM10 regulates AS in a tissue that is relevant to 
the malformations observed in the TARP syndrome and its crucial role during early 
development suggests that loss-of-function mutations of RBM10 may be 
compromising the AS regulation of selected genes leading to aberrant gene expression 
and causing human disease. 
 
                                                                                                              Rodor et al. 
 21
Materials and methods 
Cell culture 
Mouse mandibular MEPA (Mouse Embryonic Pharyngeal Arch) cell line was 
obtained, as previously described from 11.5 d.p.c. embryos from CD1 females crossed 
with a male 'Immortomouse'20. Cells were cultured in medium (DMEM, 10% FCS, 
1% penicillin/streptomycin) containing 100 U ml-1 murine -interferon (Peprotech) at 
33 °C in an atmosphere containing 5% CO2. The hemizygote RBM10Y/− gene trap ES 
cells (CSI176), as well as the parental cell line E14Tg2a.4 were obtained from 
BayGenomics. Cells were cultured in gelatin-coated plates in GMEM medium 
supplemented with 15% FCS, 2mM glutamine, 1mM sodium pyruvate, 100uM non-
essential amino acids, 100 µM b-mercaptoethanol, antibiotics and LIF. 
 
Generation of RBM10 knockout mandibular MEPA cells using CRISPR/Cas9 
technology 
To avoid off-target effects, we used the double nicking strategy with the Cas9 nickase 
mutant. We also conducted the targeting of two different exons and kept two cell lines 
for each exon targeted. Two single guide RNAs for each exon were cloned into 
pSpCas9(BB)-2A-GFP containing the nickase mutant of Cas9 (primer sequences in 
Table S4). The two plasmids were co-transfected into mandibular MEPA cells using 
Lipofectamine 2000 (Invitrogen). After 24h, single GFP positive cells were isolated 
by FACS and expanded in 96 well plates. Knockout cells were screened by western 
blot using anti-RBM10 antibody (ab72423, Abcam). Genotyping was carried out on 
gDNA extracted from cells using the Wizard® Genomic DNA Purification Kit 
(Promega). 
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Cell growth and differentiation 
Cells were seeded at the indicated numbers (150,000 for ES cells and 200,000 for md 
cells) in 6-well plates keeping their respective culture condition. After 25h and 50 
hours, cells were collected and counted using a cell counter. This analysis was done in 
triplicate. Differentiation of ES cells into embryoid bodies (EBs) was done using the 
hanging drop method (drops of 20μL medium without LIF containing 600 ES cells), 
as previously described48. After two days, EBs were collected and grown in 
suspension for another four days. 
 
iCLIP protocol 
iCLIP experiments were performed following a published protocol49, with minor 
modifications50. The immunoprecipitation (IP) step was carried out using an anti-
RBM10 antibody (ab72423, Abcam) that recognizes the two isoforms of the murine 
RBM10 proteins. Four independent experiments of the RBM10 protocol were 
performed. The four RBM10 iCLIP libraries with different barcodes were pooled 
together and sequenced on a single lane by single end sequencing 50nt on an Illumina 
HiSeq 2000 system (BGI). Equivalent volume of the control libraries was sequenced 
on a different lane. 
 
Read processing 
Sequencing data from the iCLIP experiments were processed as followed using 
mostly the tools on Galaxy server https://usegalaxy.org/. Taking advantage of the 
iCLIP specific barcodes, identical reads, corresponding to PCR duplicates, were 
removed. Sequencing artefacts were discarded. Adapter sequences at the 3’ end were 
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removed from the reads using CLIP tool. Barcode splitter tool attributed reads to each 
replicates. Reads were mapped to the Mouse July 2007 (NCBI37/mm9) genome data 
using Bowtie51, allowing only one mismatch in the seed. Only reads with only one 
genomic hit were kept. As reads come from cDNAs that have been truncated 
prematurely at the cross-linked nucleotide, we can deduce the cross-linked nucleotide 
positions that corresponds to the upstream nucleotide on the genome. 
 
Annotation and Motifs Discovery 
The cross-linked nucleotide position was used as the reference binding site. We 
annotated the cross-linked nucleotide positions based on ENSEMBL NCBI m37 and 
UCSC annotation mm9. We retrieved 20 nt sequences around the cross-linked 
nucleotides and searched for motifs on the top 1,000 sequences (ranked by total 
number of reads at the cross-linked nucleotide position). The search was done for a 6 
to 10 nucleotide long motif using MEME (http://meme-suite.org/tools/meme)27 
allowing up to 20 motifs. We also looked for enriched pentamers and calculated their 
zscore. As a control set of sequences, we used, for each RBM10 binding site, a 
sequence randomly selected within the same intron. The occurrence (pentamer 
frequency) was calculated for each pentamer in each file. The z-score was calculated 
for each pentamer as: (occurrence in iCLIP sequences – average occurrence in control 
sequences) / standard deviation of occurrence in control sequences 
 
Analysis of snRNAs binding and U2/U12 intron binding 
To study RBM10 binding to snRNAs, we mapped directly the iCLIP reads to the 
consensus sequence of the snRNAs. Only reads longer than 20nt were used for this 
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analysis. Then, we calculated the enrichment between the number of reads in RBM10 
iCLIP and the control iCLIP. 
To analyze how many U2- and U12-introns were bound by RBM10, we used the 
‘full’ list of RBM10 binding sites. We only analysed introns of expressed genes 
(using the RNA-seq data – see below). U12 introns were retrieved from the U12DB 
database28. The comparison between the proportion of U2- and U12-introns bound by 
RBM10 was done using a z-test. To analyze the distance between RBM10 binding 
site and the branch point, we predicted the branch point localization for U2 and U12 
introns. For U2 introns we used SVM-BPfinder 
(http://regulatorygenomics.upf.edu/Software/SVM_BP/)22. We only considered 
predictions with svm-score > 0 and one BP per intron. We first checked for BPs that 
that were at distance from the 3'ss within AGEZ (AG exclusion zone) length + 9nt 
and had BP sequence score > 0. If there was one, we kept that one. If there was more 
than one, we took the one with the highest svm-score. If there were none, we dropped 
the condition on the BP sequence score and selected the best svm-score. If in this case 
there was still none, we dropped the AGEZ condition and simply reported the BP with 
the highest svm-score in the intron.  To predict U12 branch points we used GeneID52 
to score the splice-sites and locate BPs using the parameters for U12 introns 28 and 
kept only those with positive scores for the branch-point and splice-sites. 
  
RNA-seq 
RNA extractions were performed using RNeasy Mini Kit (Qiagen) with DNAse 
treatment on column following manufacturer instructions. RNAs extracted from WT 
or RBM10 KO md cell lines were sent for sequencing to Beijing Genomics Institute 
(BGI). Three independent RNA extractions were carried out for the WT cell line 
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while one RNA extraction was performed for each of the four KO cell lines, 
constituting four biological replicates. The libraries have been obtained using Truseq 
Transcriptome kit (polyA transcript enrichment) and sequenced on Illumina HiSeq 
providing a minimum of 10Gb of data per sample (90bp paired end reads) at the 
Beijing Genomics Institute (BGI). For ES cells, the same analysis was done on 
triplicate of WT and RBM10 KO RNA extractions. 
 
RNA-seq bioinformatics analysis 
Reads mapping and transcript quantification were done using Sailfish30, using the 
mm10 annotation of the mouse genome. To analyze the expression of a gene, we 
pooled the estimated read counts obtained by Sailfish for its different transcripts. We 
pre-filtered the data removing the bottom 25% of genes with low expression across all 
the cell lines.  The differential expression between the WT and KO RBM10 cell lines 
was done using DESeq31. To generate heatmaps, the count values of each gene were 
first moderated by the variance stabilizing transformation (VST) method using 
DESeq. We calculated the Euclidean distances among samples and used heatmap2 
function of the gplot package to visualize the sample clustering. The Genome-wide 
analyses of pre-mRNA splicing was done using SUPPA32. This method generated a 
list of splicing events from the mm10 annotation and then used the transcript 
quantification from Sailfish to calculate the PSI value for each splicing event (or 
transcript isoform) for each RNA-seq data. We only used transcripts with a level of 
expression (transcript per million TPM) above 1. We calculated the ΔPSI between 
KO and WT conditions (mean of PSI value for the 4 KO minus the mean of PSI value 
for the 3 WT). We also needed to take into consideration the variation within each cell 
lines WT or KO. So, we calculated the standard deviation but also the overlap 
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between the two sets of data (overlap between the maximum (minimum) of the KO 
dataset and the minimum (maximum) of the WT dataset for a negative (positive) 
ΔPSI. We filtered and ranked the list of splicing changes using these three parameters 
(ΔPSI, standard deviation and overlap). 
 
RNA map 
To investigate whether RBM10 directly regulates alternative exons, we looked for 
RBM10 ‘common’ cross-linked nucleotides in introns in proximity of the events. 
iCLIP cross-linked nucleotide positions based on the mm9 annotation were converted 
to the mm10 annotation using the Lift-Over tools to compare with the RNA-seq data. 
 We found 100 silenced exons and 46 enhances cassette exon with RBM10 binding in 
the neighboring introns. We analyzed the distribution of the relative distance in 
introns using a count density plot. We also analyzed features of those regulated events 
in terms of exon length, intron length, GC content and the strength of the splice site, 
which was evaluated on line using the maximum entropy score method53 
(http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scoreseq.html). For the 
comparison, we used two control sets: alternative cassette exons not regulated by 
RBM10 in genes expressed in md cells (DESeq_mean_normalized_count>1), as well 
as alternative cassette exons not regulated by RBM10 present in genes with an event 
regulated by RBM10. 
 
Validation of splicing changes 
RNA extractions were performed using RNeasy Mini Kit (Qiagen) following 
manufacturer instructions in WT or KO. RNAs were subsequently treated with 
DNAse RQ1 (Promega) to remove any gDNA contamination. cDNA were obtained 
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using Superscript III Reverse Transcriptase (Invitrogen). The PCRs to detect the 
splicing changes were done with GoTaq Hot Start Colorless Master Mix. The 
sequences of the used primers can be found in Supplemental Table S4. The 
quantification of each isoform abundance was done using an Agilent Bioanalyzer. 
 
DATA DEPOSITION 
Raw sequencing data for both CLIP and RNA-seq experiments will be deposited in 
the Gene Expression Omnibus database. 
 
SUPPLEMENTAL MATERIAL 
Supplemental material is available for this article. 
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Figure legends 
Figure 1. Genome-wide mapping of RBM10 RNA-binding sites in a mouse 
mandibular MEPA cell line using iCLIP. (A) Autoradiograph of cross-linked 
protein/RNA complexes after immunoprecipitation and 32P RNA labelling. 
Immunoprecipitations were performed with an antibody that recognizes both isoforms 
of RBM10 protein or with IgG, as a negative control. Three different dilutions of 
RNase I were used.  Cells untreated with UV were also used as a control. Sections of 
the membrane cut for the library preparation are indicated by red boxes (B) Number 
of reads obtained for each iCLIP experiment after processing of the sequencing data 
(removal of PCR duplicates, trimming of adapter sequences, attribution of the read to 
one specific replicate using the barcode) (C) Number of cross-linked nucleotides 
obtained through all iCLIP experiments and the ones reproducibly found in several 
replicates of the iCLIP experiments. (D) Graph showing the proportion of cross-
linked nucleotides supported by more than 10 reads in the list of binding sites present 
in all 4 iCLIP experiments (‘strong’ list) or in 3 out of 4 experiments (‘full’ list). 
 
Figure 2. RBM10 binding sites. (A) Distribution of RBM10 cross-linked nucleotide 
positions among protein coding transcripts, non-coding RNAs and intergenic regions. 
(B) Distribution of RBM10 cross-linked nucleotide positions among coding exons, 
5’UTRs, 3’UTRs and introns. (C) Position of the RBM10 cross-linked positions 
within introns. The distribution of the number of intronic cross-linked nucleotide 
positions in regions upstream and downstream of the splice site is shown. (D) 
Nucleotide preference for RBM10 cross-linked positions (based on the top 1,000 
RBM10 cross-linked nucleotides in introns). (E) In vivo RBM10 binding motif 
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obtained with the MEME software using the 20nt sequences surrounding the top 
1,000 RBM10 cross-linked positions in introns. 
 
Figure 3. RBM10 binds small nuclear RNAs (snRNAs) of the major and minor 
spliceosome and their regulated introns. (A) Enrichment in the number of reads 
mapped to individual snRNAs for RBM10 iCLIP, as compared to the control. The red 
line corresponds to a ratio of 1 (i.e. no enrichment). (B) Proportion of introns spliced 
by the major or minor spliceosome that are bound by RBM10. Only introns of 
expressed genes (using RNA-seq data) have been analyzed (132,627 U2-introns and 
606 U12-introns). U12 introns were retrieved from the U12DB database28. The 
comparison between the two samples was done using a z-test. (C) RBM10 binding 
profile upstream of the 3’ splice site for U2- (n=27,123) and U12-introns (n=174). 
The density of the cross-link nucleotides was plotted. (D) RBM10 binding profile 
upstream of the branch point (BP) adenosine for U2- (n= 26,234) and U12-introns 
(n=133).  The prediction of the BP was done using SVM-BPfinder22. The density of 
the cross-link nucleotides was plotted. 
 
Figure 4. Alternative splicing changes in RBM10 KO mandibular cells. (A) Structure 
of the RBM10 gene indicating the position of the deletions in exon 3 and exon 9, 
respectively, generated using CRISPR technology. (B) Western blot showing the 
absence of RBM10 protein isoforms in four independent KO cell lines. (C) Heatmap 
showing the Euclidean distances between the RNA-seq samples as calculated from 
the variance stabilizing transformation of the count data using DESeq. Darker blue 
colors indicate more similar pattern of expression. The count data was obtained after 
mapping and transcript quantification using Sailfish30. (D) Summary of the splicing 
                                                                                                              Rodor et al. 
 34
changes observed in the four RBM10 KO md cells compared to WT. Splicing analysis 
was carried out using SUPPA software32. 
 
Figure 5. Comparison of Alternative splicing changes in mouse mandibular and ES 
cells depleted of RBM10. (A) Venn diagram showing the overlap of included or 
skipped cassette exons in RBM10 KO mandibular (md) and ES cells. (B) Validation 
of alternative cassette exon inclusion in RBM10 KO cells by RT-PCR. The size of the 
two PCR products (with or without the inclusion of the cassette exon), as well as the 
percentage of inclusion (estimated after quantification of the transcripts abundance by 
an Agilent Bioanalyzer) is indicated. We validated the splicing changes in two of the 
RBM10 KO md cells, as well as in the RBM10 KO ES cells. For AGFG2, OXR1, 
WNK1 and CIZ1, similar changes were observed in the two cells lines. ST7 splicing 
changes is more prominent in mandibular cells while NDRG2 splicing changes was 
only observed in ES cells. (C) RNA splicing map of RBM10 in mandibular cells. The 
count density of RBM10 cross-linked nucleotide positions was assessed for regulated 
alternative exons (100 silenced in red and 46 enhanced cassette exons in blue) in the 
introns upstream and downstream of the event.  
 
Figure 6. Phenotype of RBM10 KO in ES cells and mandibular cells. (A) Growth 
curve of WT and RBM10 KO ES cells. 150,000 cells were seeded in 6-well plates. 
The number of cells was analyzed after 25h and 50h. This analysis was done in 
triplicate. (B) Phase-contrast micrographs of embryoid bodies (EBs) obtained after 
differentiation of WT or RBM10 KO ES cells. Cells were cultured in suspension 
without LIF for 6 days. (C) Growth curve of WT and RBM10 KO mandibular cells. 
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200,000 cells were seeded in 6-well plates. The number of cells was analyzed after 
25h and 50h. This analysis was done in triplicate. 
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Supplemental Fig. S1. iCLIP of RBM10 in a mouse mandibular (MEPA) cell line. 
 
Supplemental Figure S2.  Analysis of RBM10 binding sites using the number of reads.  
 
Supplemental Figure S3. Identification of RBM10 binding motifs. 
 
Supplemental Fig. S4. Binding profile of RBM10 to U2 and U12 snRNAs. 
 
Supplemental Fig. S5. Characterization of RBM10 KO mandibular cell lines. 
 
Supplemental Fig. S6. Characterization of an RBM10 KO ES cell line. 
 
Supplemental Fig. S7. RNA-seq analysis of RBM10 KO ES cells. 
 
Supplemental Fig. S8. Alternative splicing regulation in RBM10 KO mandibular and ES cells. 
 
 
Supplemental Fig. S9. Proportion of RBM10 CLIP+ targets that display changes in gene 
expression and/or AS regulation 
 
Supplemental Fig. S10. Properties of cassette exons regulated by RBM10. 
 
Supplemental Figure S11. Alternative splicing analysis of the NUMB gene. 
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Table S1. Cross-linked nucleotide positions for RBM10 iCLIP in mouse md (MEPA) cells. 
Crosslinked nucleotide positions common to the 4 RBM10 iCLIP experiments or present in 3 
out of 4 RBM10 iCLIP experiments. The coordinates are based on the mm9 annotation. The 
number of reads for each iCLIP is given. 
 
Table S2.  Significant changes in gene expression in RBM10 knockout mandibular cells. List 
of significant changes obtained using DESeq for RBM10 KO mandibular MEPA cells (fold 
change>1.5, p-value<0.05) and RBM10 KO ES cells (fold change>2, p-value_adj<0.01). 
 
Table S3.  Significant alternative splicing changes detected in RBM10 mandibular ES cells. 
The ENSEMBL Id of the gene is indicated, followed by the type of events and the coordinates. 
The PSI (percentage Splice In) is indicated for each samples. The average PSI and standard 
deviation (SD) was calculated for WT and KO samples. The difference of average between KO 
and WT is indicated as well as the overlap between the two sets of data. 
 
Table S4. Primer sequences. 
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Supplemental Figure S1. iCLIP of RBM10 in a mouse mandibular (MEPA) cell line 
(A) Number of mapped reads and the deduced cross-link nucleotide positions for each 
individual RBM10 iCLIP and equivalent control. 
(B) Correlation coefficient between each iCLIP experiment. The correlation was based on 
the number of cross-link nucleotides at each genomic position. A correlation of 1 is repre-
sented by dark grey cells. A correlation between 0.7 and 0.9 is indicated by a gradient of 
red.
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Supplemental Figure S2. Analysis of RBM10 binding sites using the number of reads. 
(A) Distribution of RBM10 iCLIP reads among protein coding transcripts, non-coding 
RNAs and intergenic regions. 
(B) Distribution RBM10 iCLIP reads among coding exons, 5’UTRs, 3’UTRs and 
introns.
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Supplemental Figure S3. Identification of RBM1 0 binding motifs. 
Top 15 enriched pentamers identified in the 20nt sequences surrounding the top 1,000 
RBM10 cross-linked positions in introns. As background, we used 20nt sequences 
chosen randomly within the same introns bo und by RBM10. The zscore is indicated.
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Supplemental Figure S4. Binding profile of RBM10 to U2 and U12 snRNAs.
Histogram of RBM10 binding profile to U12 (A) and U2 (B) snRNAs. iCLIP reads were directly 
mapped to U12 and U2 consensus sequences and the enrichment between RBM10 iCLIP and 
the control was determined for each cross-linked nucleotide position (number of reads in all 
RBM10 iCLIP/number of reads in all Control iCLIP). The enrichment threshold used to draw the 
cartoon (panels C and D) is indicated by the red line. 
Strong RBM10 binding positions on U12 (C) and U2 (D) snRNAs are indicated in red on the 
secondary structure obtained from ENSEMBL. A gradient of red indicates the different values of 
enrichment. The branch site recognition site and the Sm site are indicated
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Supplemental Figure S6. Characterization of  an RBM10 KO ES cell line
(A) Cartoon showing the insertion on RBM10 gene for the Rbm10Gt(CSI176)Byg  male 
gene- trap cell line obtained from BayGenomics. A schematic of the pGT0Lxf vector, as well 
as the position of the primers used are indica ted. 
(B) Confirmation of the insertion in the RBM10  KO ES cell. 
(C) Confirmation of the absence of full-length RBM10 transcripts in the RBM10 KO ES cell. 
(D) Western blot showing the absence of RBM10 protein isoforms in the RBM10 KO ES 
cells.
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Supplemental Figure S7.  RNA-seq analy sis of RBM10 KO ES cells. 
(A) Heatmap showing the Euclidean distances between the RNA-seq samples as 
calculated from the variance stabilizing transformation of the count data using DESeq. 
Darker blues colors indicate a more similar expression. The count data was obtained 
after mapping and transcript quantification  using Sailfish. 
(B) Summary of the splicing changes observed in RBM10 KO ES cells compared to WT. 
Splicing analysis was carried out using SUPPA software.
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Supplemental Figure S8. Alternative splicing regulation in RBM10 KO mandibular and 
ES cells. 
(A) Comparison of splicing event changes in RBM10 knockout mandibular cells and 
ES cells. Genes expressed in both cell lines were analyzed and the significance of the 
overlap was calculated using a hypergeom etric distribution test. 
(B) Comparison of the expression of genes that show splicing changes exclusively in 
RBM10 KO mandibular cells (n=675), only in ES cells (n=1862) or in both cell lines 
(n=111). The y axis of the violin plot corresponds to the Log2 of the ratio between the 
expression of the gene in md cells versus its expression in ES cells. The expression 
value has been estimated using DESeq. The dashed line corresponds to similar level 
of expression in mandibular and ES cells.
genes with splicing changes
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Supplemental Figure S9. Overlap of bound and regulated RBM10 RNA targets by comparing  
iCLIP data with RNA-seq in mandibular mouse (MEPA) cells depleted of RBM10. The graph 
shows the proportion of CLIP+ genes for each category. This analysis includes 146 up-regulat-
ed genes, 142 down-regulated genes and 786 splicing-regulated genes,  in RBM10 KO md 
cells.
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Supplemental Figure S11. Alternative splicing analysis of the NUMB gene.
(A) Cartoon showing the last exons of the two main isoforms of NUMB gene. Primers 
used for the RT-PCR are indicated. 
(B) The splicing pattern of the NUMB gene was detected in WT and RBM10 KO ES cells, 
as well as in WT md cells and the four independent RBM10 KO md cell lines. 
